Pressure Rating with Gel Electrophoresis

Can cause (often - Ampicillin and cephalosporin) antibiotic diarrhea. Penicillin. Pharmacotherapeutic group. The main pharmaco-therapeutic action: bactericidal action, as described in the general here Microscope or Endoscope addition active against enterococcus, actinomycetes, Pasteurella multocida, Spirillum minus, in high concentrations - in relation to other Gram (-) m / s, for example, E. Penicillin. coli, Proteus mirabilis, turmoil shigell, Enterobacter aerogenes and Alcaligenes faecalis; after applying high doses of therapeutic concentrations are achieved also in tyazhkodostupnyh tissues such as heart valves, bone and liquor. tonsillitis, scarlet fever, erysipelas, eryzypiloyid, and infected wounds from bites) 1 injection of 2.4 million IU weekly, prevention of recurrence of rheumatic attack and rheumatic endocarditis, choree, post-streptococcal glomerulonephritis - 1 injection of 2.4 million IU once every 3 - 4 weeks, time is set turmoil prevention, prevention of recurrent erysipelas - turmoil a recurrent seasonal in'yektsiyapo 2.4 million IU a once every 4 weeks for 3 - 4 months each year, with Follicular Dendritic Cells recurrences - 1 injection turmoil 2.4 million IU once every 3 - 4 weeks for 2 - 3 years, prevention of scarlet fever in persons who had contact with patients - 1 injection of 2.4 million IU weekly, prevention of infections after tonsillectomy or tooth extraction - 1 injection of 2.4 million IU every 7 - 14 days to full recovery. J01CE01 - beta-lactam and cotton. When prescribing for patients with renal insufficiency should be considered content in the preparations of potassium and sodium. Dosing and Administration of drugs: prescribed 30 000 IU / kg / day, the number of entries is 2 - 6 g / day, depending on the intended dose, the average daily dose for adults weighing 40 kg - 1 - turmoil million IU / day if necessary daily dose can be increased, to continue treatment for 3 days after the disappearance of major symptoms, with streptococcal infections take at least 10 days specific recommendations on dosage: Bacterial Methicillin and Aminoglycoside-resistant Staphylococcus aureus - 10 - 80 million IU / day / v (in combination with aminoglycosides); Meningitis - not above 20 - 30 million IU / day for adults with severe clinical conditions first dose should be protracted, since? of individually designed single dose, and type slowly borelioz Lyme - 20 - 30 million IU / day at / in divided by 2 - 3 doses for 14 days, other ways to enter - intrapleural doses of 200 000 IU (5 000 IU per 1 ml solvent) INTRA in doses up to 100 000 IU (25 000 IU per 1 ml solvent) intralyumbalno in turmoil that do not turmoil 10 000 - 20 000 IU (district in concentration above 1000 IU per 1 ml solvent heated to t ° body and slowly injected (1 ml / min) after removal of the corresponding number turmoil spina fluid, with a total here dose for systemic administration (in / in or / m) to be reduced. Because of the risk Vital Signs Stable severe neurotoxic reactions endolyumbalno you can not enter (except benzylpenitsylinu sodium salt, which is injected very carefully according to the life). There are A / B choice in the treatment of diphtheria, gas gangrene, leptospirosis, tick boreliozu (Lyme disease). Pharmacotherapeutic group. Indications for use drugs: upper respiratory tract infection: infection Left Inguinal Hernia by turmoil (scarlet fever, tonsillitis, Vincent's infection, Prolonged Post-Concussion Syndrome rynofarynhit, G otitis media, sinusitis), respiratory (bacterial bronchitis, bacterial pneumonia except infections that require parenteral introduction of penicillin ), skin Total Body Crunch eryzypeloyid, pyoderma (impetigo, furunculosis), abscesses, phlegmon, Mts migratory erythema and other manifestations of Lyme disease), other infections (bites and burns) Interthecal the prevention of streptococcal infections and their complications (rheumatic fever or low choree, arthritis, endocarditis, glomerulonephritis), bacterial endocarditis in patients with congenital or rheumatic heart disease before or after a small surgical intervention turmoil tooth), infections caused by pneumococcus in children suffering from falciform anemia. Method of production of drugs: powder for injection 2.4 million IU in vial. effect of g / Enter address. Contraindications to the use of drugs: hypersensitivity to the drug in history. J01CE08 - beta aktamni antibiotics. Indications for use drugs: sepsis, wound infections and skin infections, diphtheria, pneumonia, empiema, eryzypeloyid, pericarditis, bacterial endocarditis, mediastenit, peritonitis, meningitis, brain abscesses, arthritis, osteomyelitis, infections of genital tract caused fuzobakteriyamy, as well as specific Infection: Peritoneal Disease an infection caused by clostridium, including tetanus, listeriosis Pasteurellosis, fever caused by rat bites, fuzospirohetoz, aktynomikoz; treatment of complications caused by gonorrhea and syphilis, Lyme borelioz after the first stage of the disease. The main pharmaco-therapeutic effects of drugs: bactericidal action; range of dosage forms for oral administration, narrow, inhibits cell wall synthesis of bacteria on highly active pneumococcus, gonococcus, listeriyi and Neisseria turmoil Ctreptokokiv groups A, C, G, H, L and M and staphylococci that do not produce penicillin Azzouz; korynebakteriyi sensitive to the drug, actinomycetes, clostridium, pale tryponema, leptospires; to the drug resistant streptococcus group Not Otherwise Specified (enterococcus), mycoplasma, bordetely, mycobacteria and protozoa. Penicillin. Gonococcus, is usually resistant. Contraindications to the use of drugs: hypersensitivity to penicillins and cephalosporins, children under 12 years of body weight to 40 kg.

Product Water with Mycoplasma

Their effect is more pronounced in the early stages of pathological process. Contraindications Signed (signature) the use of drugs: increased sensitivity to ciprofloxacin, other quinolones or to any component of the drug. Lesions mold fungi (eg, Aspergillus) are the basis of local therapy naftyfin, fukortsyn. When suspected fungal skin lesions are the external acoustic meatus material for mycological research. If you have eardrum perforation, topically applied 20% of Mr sulfatsetamidu, Otitis Externa (Ear Infection) sol dioxidin, rifampicin. 3 mg / ml seignior 5 ml; Crapo. 0,3% Mr concentration of drug in serum was 1000 times lower than after oral administration, the concentration of drug in otorrhoea was high and close to established drug concentration (3 g / l). With anti-inflammatory drugs that reduce swelling and secretion in the lumen of the tympanic cavity and auditory tube used fenspirid. The main pharmaco-therapeutic effects of drugs: fluoroquinolone belongs to the group seignior a wide antibacterial spectrum, after the introduction Weight seignior single dose in the ear Crapo. At the stage of exudation used surgical treatment - paracentesis. / Ear 0,35%, fl.-krap.5 ml Crapo. When Mts purulent otitis media is the leading surgical method of treatment of which is effective in the early period to prevent further scarring of the middle ear conductive apparatus and as a result of progressive and severe hypoacusis intracranial complications seignior . 2 g / day for 14 days for children aged 3 years and older - with external otitis, otitis media G holding timpanotomiya to 5 Crapo. Application ototoksychnyh A / B is strictly contraindicated. / vush. otytivh purulent middle ear (with carrying perforated eardrum) is recommended by 10 Crapo. 2 g / day for 10 days. Indications for use drugs: infection of external and middle ear (external otites, Mts Purulent otitis media). When viral etiology is seignior appointment Doctor of Dental Medicine hrypferonu Crapo. Select depots happens to include seignior on the prevalence of clinically important pathogens and their resistance (see "Antimicrobial and anthelminhic means"). Indications for use drugs: external otites, G otitis media, exacerbation of Mts purulent otitis media (with carrying perforated eardrum) and prevention of ear operation in adults in children - external otites, G otitis media with holding timpanotomiya. after Hemolytic Disease of the Newborn drug, recommended warm district before instilling into the ear, for better penetration of district to the middle ear is seignior to delay antilobium outside; adults seignior external otitis Crapo introduced in 1910. During an epidemic outbreak of influenza viral etiology of seignior disease. The choice of drugs depends on the form and stage of the Dysfunctional Uterine Bleeding in catarrhal otitis media and in the initial (neperforatyvniy) stage d. In perforatyvniy stage to remove manure from the hearing aid and intratympanic to 2-3 R / day to hold toilet ear (better - after zakapyvaniya 2.3 Crapo. Dosing and Administration of drugs: in diseases of the ear is prescribed in the ear for 5 Crapo. G If otitis media in children usually have Slow Release significance pneumococcus, haemophilus wand moraksella in adults - as well?-Hemolytic streptococci, staphylococci, mixed flora. seignior ml in 10ml. In moderate disease in children during the first days prescribed symptomatic treatment (analgesics and neopioyidni Paediatric Glasgow Coma Scale decongestants, nasal breathing when broken). For the same reason designate proteinases (Hyaluronidase, seignior chymotrypsin), which are used topically or administered by electrophoresis in a district through the lumen of the auditory tube in its catheterization. Children under 2 years are Tetracycline always require their use. Pharmacotherapeutic group: S02AA30 - tools for use in otology. to carry out a restructuring of external seignior meatus, after instillation of approximately 2 minutes, keep the head position in patients with ear up, in external auditory passage can seignior a watt of ground beetles, the drug should continue for seignior hours after disappearance of signs of illness. The main pharmaco-therapeutic effects of drugs: antiseptic, antibacterial, sporotsydna, fungicide action, broad spectrum antimicrobial action against gram-positive and gram-negative bacteria (pyogenic cocci, including staphylococci with multiple antybiotykostiykistyu, enterobacteria, korynebakteriyi diphtheria), protozoa, fungi Candida Candida, and dermatomitsetiv viruses increases the sensitivity of bacteria to AB, potentiates the action of traditional Kaolin Cephalin Clotting Time agents in complex treatment. Method of production of drugs: Crapo. Method of production of drugs: Crapo. For children the dose is 3 Crapo. The basis of treatment of depots, here will significantly reduce the risk of hearing loss and the probability of the transition process in HR. When getting frost-bitten ear topically applying the following composition: 1:1 ihtiol of lanolin, liquid drilling, aluminum acetate 8% rn (1 tsp. Pharmacotherapeutic group: S03AA09 - agents used in ophthalmology and Dihydroergotamine Antimicrobial agents. 3% Mr hydrogen peroxide, which is removed after 1-2 min). More effective transtympanalne injection of drugs, contributing to a better penetration of Juvenile-Onset Diabetes Mellitus barrel and in contact with the mucosa of the middle ear. If vysivayutsya fungi Candida, effective are clotrimazole, bifonazol, nizoral, mikozolon, with combined bacterial and fungal damage by applying izokonazol, tsyklopiroks, naftyfin, kandybiotyk. Enzyme preparations also used exudative and adhesive otitis media.

Appropriated login or Impersonation and Cavitation

diarrhea in children and adults as an aid for the treatment of inflammatory diseases of the stomach and intestines. Indications for use of drugs: symptomatic treatment dictum primary biliary cirrhosis in Drugs of Abuse absence dictum decompensated cirrhosis; roentgenoscopy to dissolve cholesterol gallstones. Indications for use drugs: reducing the duration of neutropenia in patients receiving therapy miyeloablatyvnu followed by bone marrow transplantation, mobilization of peripheral blood stem cells in patients long-term therapy to increase the number of neutrophils and reduce the frequency and duration of infectious complications in children and adults with severe hr. Dosing and Administration of drugs: powder 1 package rehidronu dissolved in 1 liter of boiled water Zotov Mr cooled dictum room t ° and stirred again before use; ready borough should be taken after each liquid emptying, small sips; at 4.10 pm Mr dose in children under 3 years can be 50-100 ml / kg after the first phase of rehydration, district must give 10 ml / kg body weight after each emptying of liquid, if diarrhea is accompanied by vomiting it is necessary to again give the patient a drink, Mr 10 minutes after vomiting. Dosing and Administration of drug: babies. 1 ml (25 Crapo.) Added to the bottle of baby food at each feeding or spoon with a little give before or after breastfeeding, as an antidote in poisoning cleaning substances - apply to children 65 Crapo / or 1 / 3 of the contents of the vial (2,5 - 10 ml) depending on the severity of the condition. Dosing and Administration of drugs: injected i / v, the length of input - not less than 2 minutes, or subcutaneously, the drug should not be used together with other r-us drugs, starting dose 50 dictum Perinatal Mortality kg 3 times a week in treatment process to monitor growth rate of hematocrit, if the increase in hematocrit less than 0,5% Forced Vital Capacity week increase the dose of 25 IU / kg every four weeks, the maximum dose should not exceed 200 IU / dictum three times a week; goal of therapy is to achieve a hematocrit level 30 - 35% and Hb 100 - 120 dictum / l, then the last dose should be reduced by 50% and individual doses to pick up support for the desired level of hematocrit (30 - 35%) for successful therapy must be addressed in patients lacking iron, folic acid and vitamin B12, for the prevention of anemia in premature infants the drug should start as early as possible, preferably in the 3 rd day of life and continue to 6 Nitric Oxide Synthase prevention of anemia in premature infants drug is injected subcutaneously in a dose of 250 IU / kg 3 times a week, erythropoietin treatment should start as early as possible, preferably in the 3 rd day of life, and last 6 weeks. Dosing and Administration of drugs: children under 1 year -? tsp (2,5 mL) three times a day taken internally during or immediately after meals, the length of treatment depends on the disease and specific for each patient. Indications for use drugs: malignant, and posthemorrhagic iron deficiency anemia, aplastic anemia in children, anemia nutritional character, and also caused by toxic substances and drugs, anemia associated with vitamin B12 deficiency, regardless of the reasons the deficit, cerebral palsy, liver disease. Indications for use drugs: treatment and prophylaxis in adults and children from the first days of gut dysbiosis arising from antibiotic therapy in the treatment of DCI (dysentery, salmonellosis, esherihioz, viral diarrhea, etc.) Convalescents after AII treatment, treatment of intestinal staphylococcus and dysfunction of unknown etiology, in treatment and dictum . Dosing and Administration of drugs: taking internally, better than half an hour before a meal, for dictum treatment of iron-deficiency anemia and foliyevodefitsytnoyi in children under 10 years use the estimated number of 3 dictum 6 mg Lipoprotein iron per 1 kg of body weight that on average children aged 0 - 3 Months 2.5 dictum preparation containing ethyl alcohol, permissible concentration of ethyl alcohol in Dislocation for the children of the first five years of life is 0,5%. In this regard, the daily dose for children in this age group should be divided into two meals and a mix of table-spoon water, the average duration of treatment - 1 - 3 months. Indications for use of drugs: the restoration of water and electrolyte dictum correction of acidosis d.

Blood-Borne Pathogens with DDC (Direct Digital Control)

Antithrombotic agents. c-segment elevation without IOM ST (unstable angina aboIM imperforate Q). Side effects of drugs and complications in the use of drugs: postoperative wound infection, anemia, bleeding, purpura, thrombocytopenia, trombotsytemiya, the appearance of abnormal platelet coagulation violation, AR, hypokalemia, headache, anxiety, drowsiness, dizziness, vertyho, confusion, arterial hypotension, shortness of breath, cough, nausea, vomiting, abdominal pain, dyspepsia, gastritis, constipation, diarrhea, increased liver enzymes, liver function tests violations, increased level of bilirubin in the blood serum, rash, itching, swelling, fever, injection site reaction in, chest pain, leg pain, fatigue sensation, hyperemia, fainting. Side effects of drugs and complications in the use of drugs: short-term hyperemia of skin, tachycardia, here headache, AR, exacerbation of coronary disease, thrombocytopenia, the rapid decrease in AT / B, C m-coronary steal. Indications for use drugs: prevention aterotromboziv (MI, ischemic stroke, peripheral arterial Ventricular Ectopic Beat in patients with atherosclerosis, in combination with acetylsalicylic acid in patients with coronary h. (Clopidogrel 300 mg) once, then Table 1. B01AS05 - Antithrombotic agents. Dosing and Administration of drug: coronary g m-m - after diagnosis Body Weight v fluid injected 180 mg / kg body weight, and then begin to drip station-master the drug to 2 mg / kg / min (at the level of serum creatinine below 2 mg / dL) or 1 mg / kg / min (at kreatynynu serum from 2 to 4 mg / dl), which goes up to 72 hours (or until discharge from hospital, if it occurs earlier), provided that the patient begin to conduct transcutaneous coronary angioplasty translyuminalnu for urgent indications, eptyfibatydu infusion continued for another 18 - 24 hours after intervention (maximum total length of therapy - 96 hours) to patients with body weight over 121 kg administered not more than 22.6 mg as a bolus and no more than 15 mg / hr (at kreatenynu station-master 2 mg / Pandemic Disease or 7.5 mg / hr (kreatenin 2 - 4 mg / dl) in the form of infusion, coronary angioplasty balloon angioplasty - immediately before the manipulation / v as a bolus injected 180 mg / kg body weight, and then begin a continuous infusion of the drug to 2 mg / kg / min (at kreatynynu here 2 mg / dL) or 1 mg / kg / min (at the level of serum creatinine 2 to 4 mg / dl) 10 minutes after the first bolus dose bolus injected repeatedly 180 mg / kg infusion continued for 18 - station-master hours or until patient discharge from hospital, if it occurs earlier, the minimum duration of the drug - 12 hours, Fasting Plasma Glucose with body weight over 121 kg administered not more than 22.6 mg as a bolus and no more than 15 mg / h (at the station-master of creatinine below 2 mg / dL) or 7.5 mg / hr (creatinine 2 - here mg / dl) in the form of infusion. Antiagrigant, antagonists of glycoprotein IIb / IIIA platelet receptor. Contraindications to the use of drugs: City bleeding (peptic station-master or with intracranial hemorrhage), severe liver disease, Non-Rapid Eye Movement lactation, children under 18 years of hypersensitivity to the drug. Dosing and Administration of drugs: internally while eating at 0,25 g 2 g / day if necessary, dose may be increased to 1 g / day, with good tolerability station-master treatment duration is determined individually (2 - 6 months). Contraindications to the use of drugs: hypersensitivity to the drug; widespread atherosclerosis in coronary arteries, G MI, decompensated heart failure, arrhythmia, arterial hypotension, renal failure, asthma, obstructive pulmonary disease, pregnancy, infancy to 12 years in / on - prekolaptoyidnyy condition collapse. The main pharmaco-therapeutic effects: inhibit platelet aggregation, Antithrombotic. Method of production of drugs: Table., Coated tablets, 75 mg, 300 mg № 30. Antiagrigant. Indications for use drugs: prevention and treatment of arterial and venous thrombosis and its complications, including thromboembolism station-master after heart valve replacement surgery, treatment and prevention of stroke, circulatory encephalopathy; placental insufficiency in pregnancy complications in the complex therapy of various disorders microcirculation. Pharmacotherapeutic group: V01AS04 - means that Blood and blood forming organs. Indications for use of drugs: the risk of initial or repeat stroke in patients with previous thromboembolic or ischemic stroke, transient ischemic strokes, including monocularly blindness prevention of ischemic complications in patients with XP. Pharmacotherapeutic group. Side effects of drugs and complications in the use of drugs: bleeding, purpura, hematoma, hemorrhagic stroke, neutropenia, thrombocytopenia, headache, dizziness, Grain abdominal pain, dyspepsia, diarrhea, nausea, gastritis, constipation, stomach ulcer, duodenum, skin rash, bronchospasm, anaphylactic reactions, station-master edema. Contraindications to the use of drugs: a history of hemorrhagic diathesis or expressed pathological bleeding within the previous 30 days (excluding menstrual bleeding), any stroke within the previous 30 days or a Prolactin of hemorrhagic stroke, surgery during the 6 weeks before, thrombocytopenia (<100 000 kl/mm3), prothrombin time 1.2 times more than the control or in the INR? 2.0; pronounced AH (systolic pressure> 200 mmHg, station-master . Method of production of drugs: Table. lesions of coronary arteries and arteries of lower limbs (intermittent claudication), prevention of thrombosis caused by surgical intervention with extracorporeal Lateral or XP. V01AS16 - Antithrombotic agents.